Istanbul University
Istanbul, Turkey (Türkiye)
NCT Number: NCT07555080
This study aims to compare the gastric volumes of pediatric patients undergoing positive-pressure ventilation with different airway management techniques. Gastric ultrasound is a non-invasive bedside tool with high sensitivity and specificity for determining the nature and amount of gastric content. In pediatric cases, maintaining a gastric volume below 1.25 mL/kg is associated with a lower risk of perioperative aspiration.
Although supraglottic airway devices (SADs) are commonly used as alternatives to endotracheal tubes, concerns regarding the potential for gastric insufflation and subsequent aspiration persist. Second-generation SADs were specifically designed with gastric drainage channels to mitigate the risk of regurgitation compared to first-generation devices.
The primary objective of this study is to determine whether there is a difference in gastric volumes, as measured by ultrasound, among three groups of pediatric patients: those managed with endotracheal tubes, first-generation SADs, and second-generation SADs. By comparing these measurements post-ventilation, the investigators aim to evaluate the impact of the airway device choice on gastric volume under clinical conditions.
Trial opening soon.
Get Notified1 year–10 year
All sexes
Observational
Istanbul, Turkey (Türkiye)
All participants will receive a standard preoperative intravenous (IV) dose of 0.1 mg/kg midazolam in the preparation room. Upon arrival at the operating room, routine monitoring will be established for all patients, including electrocardiography (ECG), non-invasive blood pressure (NIBP), and peripheral oxygen saturation (SpO2). Before the induction of anesthesia (T0), the gastric antral area will be evaluated using ultrasound in the right lateral decubitus (RLD) position. A high-frequency linear probe will be placed sagittally in the epigastric region to visualize the stomach antrum, located posterior to the left lobe of the liver and anterior to the abdominal aorta. The largest and smallest diameters (d1 and d2) of the elliptical antrum will be measured. The Antral Cross-Sectional Area (ACSA) will be calculated using the formula: ACSA = d1*d2*pi/4. Gastric volume will then be derived using the validated pediatric formula: [0.035*ACSA (mm2) + 0.127*age (months) - 7.8] / body weight (kg). Standard general anesthesia induction will be performed using sevoflurane and oxygen inhalation, 1 mcg/kg IV fentanyl, and 0.5 mg/kg IV rocuronium. Following induction, patients will be managed with either endotracheal intubation or a supraglottic airway device (SAD). The choice of airway management will follow routine clinical practice. SAD size and cuff inflation volume will adhere to the manufacturer's recommendations. Any volume leakage during ventilation will be recorded as a percentage. Anesthesia maintenance will be provided with 1 MAC sevoflurane in an oxygen/air mixture. The gastric antral area will be re-evaluated via ultrasound in the RLD position at two additional time points: T1: Immediately after the airway device is secured and ventilation is established, before the start of surgery. T2: At the end of the surgical procedure, before the patient emerges from anesthesia. All relevant clinical data will be recorded in the patient follow-up form, including age, gender, height, weight, duration of surgery, vital signs, type of airway device used, perioperative airway pressures, and any observed complications. Following the final measurement, patients will be emerged from anesthesia and transferred to the postoperative recovery room according to standard protocols.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 2 hours
The primary outcome is to compare the change in gastric volume calculated via ultrasound at T0 (before induction), T1 (after the airway secured), and T2 (end of the operation) among the three groups (Endotracheal tube, first-generation SAD, and second-generation SAD). This will determine whether the choice of airway device leads to a difference in gastric volume during the perioperative period.
Time frame: 30 minutes to 2 hours
Total duration of the surgical procedure and the change in gastric volume
Time frame: up to 2 hours
Meauserement of antral cross sectional area at T0, T1 and T2 on lateral decubitis position
Time frame: up to 2 hours
Air leakage percentage with different airway devices
Time frame: up to 2 hours
Peak airway pressures during surgery duration
Time frame: up to 2 hours
Pulse oximeter
Time frame: up to 2 hours
ECG monitoring
Time frame: up to 2 hours
Non-invasive blood pressure measurement
Time frame: up to 3 hours
Perioperative airway complications such as bronchospasm, laryngospasm etc. will be noted
Contact information is provided by the study sponsor or research team.
Meltem Savran Karadeniz, Professor
CONTACT
Zeynep Sandikci, Resident
CONTACT
Istanbul University
Other
Comparison of Gastric Volume Changes Via Ultrasound After Ventilation With Endotracheal Tube, First-Generation Supraglottic Airway, and Second-Generation Supraglottic Airway in Pediatric Patients: A Prospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07196137
Elective Surgeries, Gastric Insufflation
Ankara, Çankaya, Turkey (Türkiye)
View Trial DetailsNCT05959135
Behavior, Diabetes Mellitus
Sarıyer, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07483593
Diabetes Mellitus, Endocrine System Diseases
Kocaeli, Turkey (Türkiye)
View Trial DetailsNCT07480031
Gastric Insufflation
Banhā, Egypt
View Trial Details